In this Review:
Full-dose bivalirudin post-PCI mitigates bleeding
Aldosterone blockade in MI without HF: no benefit
Bioresorbable scaffold vs a metallic drug-eluting stent in STEMI
Cyclosporine does not prevent reperfusion injury
Celecoxib vs NSAIDs in arthritis patients without known CV disease
Rapid rule-out protocol accelerates MI triage
Novel HCM score for CV risk prevention in athletes
CTA/FFRCT improves patient selection for invasive catheterisation
Spironolactone: optimal treatment for drug-resistant hypertension?
Extend clopidogrel after drug-eluting stent placement?
Please login below to download this issue (PDF)